Enzastaurin cardiotoxicity: QT interval prolongation, negative inotropic responses and negative chronotropic action
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enzastaurin cardiotoxicity: QT interval prolongation, negative inotropic responses and negative chronotropic action
Authors
Keywords
-
Journal
BIOCHEMICAL PHARMACOLOGY
Volume -, Issue -, Pages 115443
Publisher
Elsevier BV
Online
2023-01-30
DOI
10.1016/j.bcp.2023.115443
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of gefitinib-induced QT prolongation
- (2021) Ling-Jun Jie et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Adverse Cardiovascular Effects and Cardiotoxicity of Kratom (Mitragyna speciosa Korth.): A Comprehensive Review
- (2021) Mohammad Farris Iman Leong Bin Abdullah et al. Frontiers in Pharmacology
- ENGINE: a Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1
- (2020) Grzegorz S Nowakowski et al. Future Oncology
- Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs
- (2020) Agapios Sachinidis Cells
- Revisiting the hERG safety margin after 20 years of routine hERG screening
- (2020) Derek J. Leishman et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Time for a Fully Integrated Nonclinical–Clinical Risk Assessment to Streamline QT Prolongation Liability Determinations: A Pharma Industry Perspective
- (2020) Hugo M. Vargas et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Myocardial Dysfunction after Severe Food Restriction Is Linked to Changes in the Calcium-Handling Properties in Rats
- (2019) Adriana Fernandes de Deus et al. Nutrients
- Mechanical stretch increases L-type calcium channel stability in cardiomyocytes through a polycystin-1/AKT-dependent mechanism
- (2018) A. Córdova-Casanova et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts
- (2018) Bo Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma
- (2016) Michael Crump et al. JOURNAL OF CLINICAL ONCOLOGY
- SKF-96365 blocks human ether-à-go-go-related gene potassium channels stably expressed in HEK 293 cells
- (2016) Hui Liu et al. PHARMACOLOGICAL RESEARCH
- A pharmacokinetic and safety study of a fixed oral dose of enzastaurin HCl in native Chinese patients with refractory solid tumors and lymphoma
- (2016) Xueying Li et al. Oncotarget
- The synergistic effect of BCR signaling inhibitors combined with an HDAC inhibitor on cell death in a mantle cell lymphoma cell line
- (2015) Kazumi Hagiwara et al. APOPTOSIS
- Effects of enzastaurin and its metabolites on the QT interval in cancer patients
- (2015) Pamela A. Welch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- QT interval correction assessment in the anesthetized guinea pig
- (2015) Pierre Morissette et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study
- (2014) L. B. Kilburn et al. NEURO-ONCOLOGY
- Mechanisms of Altered Ca 2+ Handling in Heart Failure
- (2013) Min Luo et al. CIRCULATION RESEARCH
- Slow Delayed Rectifier Potassium Current Blockade Contributes Importantly to Drug-Induced Long QT Syndrome
- (2013) Christiaan C. Veerman et al. Circulation-Arrhythmia and Electrophysiology
- A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
- (2013) Eric Jourdan et al. LEUKEMIA & LYMPHOMA
- Modulation of Pancreatic Tumor Potential by Overexpression of Protein Kinase C β1
- (2013) Stéfano M. Cirigliano et al. PANCREAS
- A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer
- (2012) Bjørn H. Grønberg et al. LUNG CANCER
- Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
- (2011) Christiane Querfeld et al. LEUKEMIA & LYMPHOMA
- A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
- (2011) Teri N. Kreisl et al. NEURO-ONCOLOGY
- Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
- (2011) N. Butowski et al. NEURO-ONCOLOGY
- Role of hERG potassium channel assays in drug development
- (2010) Birgit Priest et al. Channels
- The selective estrogen receptor modulator raloxifene inhibits cardiac delayed rectifier potassium currents and voltage-gated sodium current without QTc interval prolongation
- (2010) Hui Liu et al. PHARMACOLOGICAL RESEARCH
- Protein Kinase Cβ Is an Effective Target for Chemoprevention of Colon Cancer
- (2009) Alan P. Fields et al. CANCER RESEARCH
- Pharmacologically Induced Long QT Type 2 Can Be Rescued by Activation of IKs With Benzodiazepine R-L3 in Isolated Guinea Pig Cardiomyocytes
- (2009) Jakob Dahl Nissen et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Control of heart rate by cAMP sensitivity of HCN channels
- (2009) J. Alig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
- (2008) C Tekle et al. BRITISH JOURNAL OF CANCER
- Centrosomal PKC II and Pericentrin Are Critical for Human Prostate Cancer Growth and Angiogenesis
- (2008) J. Kim et al. CANCER RESEARCH
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
- (2008) Ming Hui Chen et al. CIRCULATION
- Enzastaurin renders MCF-7 breast cancer cells sensitive to radiation through reversal of radiation-induced activation of protein kinase C
- (2008) Piotr Jasinski et al. EUROPEAN JOURNAL OF CANCER
- Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cβ inhibitor, in non-small cell lung cancer cells
- (2008) Floriana Morgillo et al. MOLECULAR CANCER THERAPEUTICS
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
- (2007) F. Morschhauser et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started